Abstract:The treatment of triple-negative breast cancer (TNBC) remains a challenging issue in clinical settings due to the absence of effective therapeutic targets. Recent studies have revealed that transient receptor potential vanilloid type 1 (TRPV1), a non-selective Ca 2+ channel responsive to noxious thermal stimuli, is frequently overexpressed in both malignant breast cancers and vascular cells, expected to be a promising therapeutic target. Herein, we developed a second near-infrared (NIR-II) photothermal nanoplatform named CT@hCuS to enhance immunotherapy and exacerbate tumor starvation, constructed from hollow CuS nanoparticles (hCuS) with tannic acid (TA) surface-coating and efficient Ca 2+ loading via stable TA/Ca 2+ complexation. The CT@hCuS platform releases Ca 2+ in response to the mildly acidic pH of the tumor microenvironment. When exposed to intermittent 1064 nm laser irradiation, CT@hCuS delivers precise and controllable photothermy while avoiding potential adverse events of chemical TRPV1 agonists, activating TRPV1 and initiating an intracellular influx of Ca 2+ , which could not only destroy tumor vessels but also induce the immunogenic death of tumor cells. The resulting tumor antigens can be captured by CT@hCuS through binding with TA, leading to in situ tumor vaccination. Moreover, the nanoplatform via local administration contributes to durable drug release. Both in vitro and in vivo experiments demonstrated that CT@hCuS, combined with intermittent NIR-II laser irradiation, significantly enhanced the synergistic effects of intracellular Ca 2+ elevation for tumor vaccination and tumor vascular disruption, which not only selectively block tumor nutrient sources but also transforms the immunosuppressive tumor environment into an immunoreactive phenotype for inhibiting TNBC growth and metastasis. This work presents a powerful NIR-II photothermal nanoplatform and proposes a unique synergistic strategy of immunotherapy and vascular disruption therapy for clinical TNBC treatment.

Remote Manipulation of TRPV1 Signaling by Near‐Infrared Light‐Triggered Nitric Oxide Nanogenerators for Specific Cancer Therapy

Ion channel-targeting near-infrared photothermal switch with synergistic effect for specific cancer therapy

Near-Infrared-Triggered Release of Ca2+ Ions for Potential Application in Combination Cancer Therapy.

Nanomedicine‐Enabled Photonic Thermogaseous Cancer Therapy

Semiconducting Photothermal Nanoagonist for Remote-Controlled Specific Cancer Therapy

Near-Infrared Light-Triggered Nitric Oxide Nanogenerators for NO-Photothermal Synergistic Cancer Therapy

Remote Manipulation of ROS-Sensitive Calcium Channel Using Near-Infrared-Responsive Conjugated Oligomer Nanoparticles for Enhanced Tumor Therapy In Vivo

Facile Fabrication Of A Near-Infrared Responsive Nanocarrier For Spatiotemporally Controlled Chemo-Photothermal Synergistic Cancer Therapy

Near Infrared Light Triggered Nitric Oxide Releasing Platform Based on Upconversion Nanoparticles for Synergistic Therapy of Cancer Stem-Like Cells

Efficient Near Infrared Light Triggered Nitric Oxide Release Nanocomposites for Sensitizing Mild Photothermal Therapy

Near‐Infrared‐Light Remote‐Controlled Activation of Cancer Immunotherapy Using Photothermal Conjugated Polymer Nanoparticles

A NIR-II photothermal nanoplatform integrating intracellular Ca 2+ elevation via TRPV1 activation for enhanced antitumor Therapy: A powerful combination of in situ tumor vaccination and vascular disruption

Stimuli-responsive Nitric Oxide Generator for Light-Triggered Synergistic Cancer Photothermal/gas Therapy

Near‐Infrared Laser‐Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer

A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy.

Near-Infrared Light-Triggered Switchable Nanoparticles for Targeted Chemo/Photothermal Cancer Therapy

Intracellular Ca2+ Cascade Guided by NIR-II Photothermal Switch for Specific Tumor Therapy

Near-infrared Light Switching Nitric Oxide Nanogenerator with “linkage Mechanism” for Tumor Targeting Multimodal Synergistic Therapy

Nitric Oxide Modulating Calcium Store for Ca2+‐Initiated Cancer Therapy

Nitric Oxide Modulating Calcium Store for Ca 2+ ‐Initiated Cancer Therapy

Nitric Oxide-Activated "Dual-Key-One-Lock" Nanoprobe for in Vivo Molecular Imaging and High-Specificity Cancer Therapy